3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Stomach Neoplasms
2
Nasopharyngeal Carcinoma
2
Lymphoma, Large B-Cell, Diffuse
2
Carcinoma, Hepatocellular
2
Advanced Solid Tumor
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Rectal Neoplasms
1
Pheochromocytoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Paraganglioma, Extra-Adrenal
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma Metastatic
1
Osteosarcoma
1
Neoplasms by Histologic Type
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Lymphoma
1
Lung Neoplasms
1
Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
1
Gynecological Cancer
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Esophageal Squamous Cell Carcinoma
1
Interventions
Cisplatin
41
Gemcitabine
25
Fluorouracil
15
Radiotherapy, Intensity-Modulated
14
Radiotherapy
12
Docetaxel
10
pembrolizumab
8
Paclitaxel
8
Carboplatin
8
Capecitabine
7
Oxaliplatin
5
toripalimab
4
spartalizumab
4
Bevacizumab
4
camrelizumab
3
Nivolumab
3
Induction Chemotherapy
3
Endostatins
3
Cetuximab
3
Acupuncture Therapy
3
tislelizumab
2
sintilimab
2
nimotuzumab
2
endostar protein
2
apatinib
2
Taxes
2
Surveys and Questionnaires
2
Polymerase Chain Reaction
2
Nicotine
2
Magnetic Resonance Spectroscopy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Nasopharyngeal Neoplasms
×
penpulimab
×
Clear all
NCT05807880
2026-01-23
ALTER-HN005
Sun Yat-sen University
Phase 2
Active not recruiting
59 enrolled